1. Adherence to Secondary Prevention Medications and Four-year Outcomes in Outpatients with Atherosclerosis 
Dharam J. Kumbhani, MD, SM, MRCP, Ph. Gabriel Steg, MD, Christopher P. Cannon, MD, Kim A. Eagle, MD, Sidney C. Smith, MD, Elaine Hoffman, PhD, Shinya Goto, MD, E. Magnus Ohman, MD, Deepak L. Bhatt, MD, MPH 
The American Journal of Medicine 
Volume 126, Issue 8, Pages e1 (August 2013)
DOI: /j.amjmed
Copyright © 2013 Elsevier Inc. Terms and Conditions

2. Figure 1
Cumulative hazard curves for the primary end point of cardiovascular death/myocardial infarction/stroke (A) and all-cause mortality (B) based on adherence at baseline and 1 year (P < .001 for both curves by log-rank test). CVD = cerebrovascular disease; MI = myocardial infarction.
The American Journal of Medicine  , e1DOI: ( /j.amjmed )
Copyright © 2013 Elsevier Inc. Terms and Conditions

3. Supplemental Figure
CONSORT flow diagram of study participants. REACH = REduction of Atherothrombosis for Continued Health.
The American Journal of Medicine  , e1DOI: ( /j.amjmed )
Copyright © 2013 Elsevier Inc. Terms and Conditions